Waters and BD combine biosciences and diagnostics business in $17.5 billion deal

Waters Corporation and BD (Becton, Dickinson and Company) have announced a definitive agreement to combine BD's Biosciences & Diagnostic Solutions business with Waters in a Reverse Morris Trust transaction valued at approximately $17.5 billion. The combined company is expected to have pro forma 2025 sales of approximately $6.5 billion.

“Waters Corporation and BD today announced a definitive agreement to combine BD's Biosciences & Diagnostic Solutions business with Waters.”news.bd.com

• 1 source
• news.bd.comBD Newsroom - Press releasesJul 14, 2025

Summarized from public sources; check the original articles before acting on it.